Author:
Geertsen Ralf,Yue F.-Y.,Pavlovic J.,Laine E.,Dummer R.
Reference32 articles.
1. J.C. Bystryn, 1989; Immunosurveillance and melanoma. J Invest Dermatol 92, S318–320
2. R. Zakut, S.L. Topalian, Y. Kawakami, M. Mancini, S. Eliyahu and S.A. Rosenberg, 1993; Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines. Cancer Res 53, 5–8
3. A.B. Bakker, M.W. Schreurs, B.A. de, Y. Kawakami, S.A. Rosenberg, G.J. Adema and CG. Figdor, 1994; Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 179, 1005–1009
4. Y. Kawakami, S. Eliyahu, K. Sakaguchi, P.F. Robbins, L. Rivoltini, J.R. Yannelli, E. Appella and S.A. Rosenberg, 1994; Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180, 347–52
5. J.C. Becker, T. Brabletz, C. Czerny, C. Termeer and E.B. Brocker, 1993; Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4+ human T cell clone by the autologous MHC class II+ melanoma. Int Immunol 5, 1501–8
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献